Mcp and Mesna drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mcp (pectin) and Mesna (mesna). Common drug interactions include leukopenia among females and bk virus infection among males.
The phase IV clinical study analyzes what interactions people have when they take Mcp and Mesna. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.
What is Mcp?
Mcp has active ingredients of pectin. eHealthMe is studying from 2,077 Mcp users. Check the latest studies of Mcp.
What is Mesna?
Mesna has active ingredients of mesna. eHealthMe is studying from 9,647 Mesna users. Check the latest studies of Mesna.
32 people who take Mcp and Mesna together, and have interactions are studied.

What are the common drug interactions of Mcp and Mesna, by gender? *:
female:
- Leukopenia (less number of white blood cells in blood)
- Neutropenia (an abnormally low number of neutrophils)
- Thrombocytopenia (decrease of platelets in blood)
- C-reactive protein increased
- Hypokalaemia (low potassium)
- Hypotension (abnormally low blood pressure)
- Nausea (feeling of having an urge to vomit)
- Peritonsillar abscess (painful pus filled inflammation of the tonsils and surrounding tissues)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
male:
- Bk virus infection
- Cystitis viral (inflammation of the wall of the bladder by virus)
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Depression
- Hepatic failure (liver failure)
- Burkitt's lymphoma (cancer of the lymphatic system)
- Device related infection
- Febrile neutropenia (fever with reduced white blood cells)
- Hepatic mass
- Splenomegaly (enlargement of spleen)
What are the common drug interactions of Mcp and Mesna, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Burkitt's lymphoma (cancer of the lymphatic system)
- Febrile neutropenia (fever with reduced white blood cells)
- Hepatic mass
- Pyrexia (fever)
- Splenomegaly (enlargement of spleen)
40-49:
- Bk virus infection
- Cystitis viral (inflammation of the wall of the bladder by virus)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Febrile neutropenia (fever with reduced white blood cells)
- Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
50-59:
- Leukopenia (less number of white blood cells in blood)
- Neutropenia (an abnormally low number of neutrophils)
- Peritonsillar abscess (painful pus filled inflammation of the tonsils and surrounding tissues)
- Pulmonary embolism (blockage of the main artery of the lung)
- Device related infection
60+:
- Thrombocytopenia (decrease of platelets in blood)
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Diarrhoea
- Neuropathy peripheral (surface nerve damage)
- Peripheral vascular disorder
- Abdominal discomfort
- Colitis (inflammation of colon)
- Delirium (wild excitement)
- Escherichia sepsis (bacterial infection by escherichia coli)
What are the existing conditions these people have? *
- High Blood Pressure: 18 people, 56.25%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 9 people, 28.12%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 25.00%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 7 people, 21.88%
- Nausea (feeling of having an urge to vomit): 6 people, 18.75%
- Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 4 people, 12.50%
- Sleep Disorder: 4 people, 12.50%
- High Blood Cholesterol: 3 people, 9.38%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 9.38%
- Abdominal Discomfort: 3 people, 9.38%
* Approximation only. Some reports may have incomplete information.
Do you take Mcp and Mesna?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Mcp and Mesna:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mcp:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mesna:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mcp and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mesna and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pectin and mesna (the active ingredients of Mcp and Mesna, respectively), and Mcp and Mesna (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lisinopril cause Fear? - now
- Drug interactions of Flonase and Cromolyn Sodium - 10 seconds ago
- Drug interactions of Zinecard and Ifosfamide - 21 seconds ago
- Drug interactions of Glucagon and Norvasc - 22 seconds ago
- Drug interactions of Apixaban and Renvela - 25 seconds ago
- Drug interactions of Aciphex and Amoxicillin - 27 seconds ago
- Drug interactions of Lymecycline and Alendronic Acid - 29 seconds ago
- Drug interactions of Codeine and Azelastine Hydrochloride - 35 seconds ago
- Drug interactions of Pamidronate Disodium and Vicodin - 46 seconds ago
- Drug interactions of Hctz and Detrol - 54 seconds ago